With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Preclinical Development of Atr Inhibitor VE-822, Delivered Systemically in Nanoparticles, for Medulloblastoma Therapy||University of North Carolina / Timothy Gershon, MD, PhD||Innovation Grants||2015||North Carolina|
|Synergistic Differentiation Therapy in Neuroblastoma||Duke University / Gerard Blobe, M.D./Ph.D||Innovation Grants||2015||North Carolina|
|Enhanced Drug Repurposing Screen in DSRCT Enabled by New In Vitro and In Vivo Models Based on CRISPR/Cas9 Genome Engineering||Memorial Sloan-Kettering Cancer Center / Marc Ladanyi, MD & Maria Jasin, PhD||Innovation Grants||2015||New York|
|Functional Dissection of Oncogenic Enhancers in T-ALL||Columbia University / Daniel Herranz, PhD||Young Investigator Grants||2015||New York|
|Cure Osteosarcoma Lung Metastasis by Disrupting Tumor VCAM-1 Signaling with Macrophages||Case Western Reserve University / Alex Huang, MD, PhD||Innovation Grants||2015||Ohio|
|The Effect of Locus of Care Upon Adolescent and Young Adults Cancer Outcomes: An IMPACT Cohort Study||Hospital for Sick Children / Sumit Gupta, MD, PhD||Young Investigator Grants||2015||Ontario|
|Molecular Annotation for Treatment of Childhood Cancers Trial: Neuroblastoma (MATCH-NB)||Children's Hospital of Philadelphia / Yael Mosse, M.D.||Bio-Therapeutic Impact Award||2015||Pennsylvania|
|CAMKV as a Target for Immunotherapy in MYCN-Amplified Neuroblastoma||Children's Hospital of Philadelphia / Robyn Sussman, PhD||Young Investigator Grants||2015||Pennsylvania|
|Next-Generation Personalized Neuroblastoma Therapy (Nepenthe)||Children's Hospital of Philadelphia / Yael Mosse, MD & John Maris, MD||Bio-Therapeutic Impact Award||2015||Pennsylvania|
|Inside-Out Immunotherapy: Combating Neuroblastoma via Nanoparticle-Directed Reprogramming of the Tumor Microenvironment||Vanderbilt University Medical Center / John Wilson, PhD||'A' Award Grants||2015||Tennessee|